A rapid fabricated living dermal equivalent for skin tissue engineering: An in vivo evaluation in an acute wound model

Tissue Engineering - Part A

Volumn 18, Issue 3-4, 2012, Pages 353-361

  Ananta, Michael ^a   Brown, Robert A ^a   Mudera, Vivek ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD VESSELS; CELL CULTURE; FABRICATION; MECHANICAL PROPERTIES; MONOLAYERS; SAFETY TESTING; TISSUE; TISSUE ENGINEERING;

CHRONIC WOUNDS; DERMAL EQUIVALENT; DIABETIC ULCERATION; FABRICATION TIME; HIGH COSTS; IN-VITRO; IN-VIVO; KERATINOCYTES; MECHANICAL COMPRESSION; SKIN DEFECTS; SKIN EQUIVALENTS; SKIN TISSUE ENGINEERING; SURGICAL MESHES; VESSEL FORMATION; WOUND CLOSURE; WOUND DRESSINGS;

LIVING POLYMERIZATION;

LEPORIDAE;

CD31 ANTIGEN; CD45 ANTIGEN;

ANIMAL; ARTICLE; ARTIFICIAL SKIN; CELL COUNT; CELL SURVIVAL; DERMIS; DISEASE MODEL; EPIDERMIS; IMMUNOHISTOCHEMISTRY; INJURY; KERATINOCYTE; MALE; METABOLISM; METHODOLOGY; PATHOLOGY; PHYSIOLOGY; RABBIT; TISSUE ENGINEERING; WOUND HEALING;

ANIMALS; ANTIGENS, CD31; ANTIGENS, CD45; CELL COUNT; CELL SURVIVAL; DERMIS; DISEASE MODELS, ANIMAL; EPIDERMIS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; MALE; RABBITS; SKIN, ARTIFICIAL; TISSUE ENGINEERING; WOUND HEALING; WOUNDS AND INJURIES;

EID: 84856273193     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2011.0208     Document Type: Article

References (43)

1. Elsdale, T., and Bard, J. Collagen substrata for studies on cell behavior. J Cell Biol 54, 626, 1972.
2. Helary, C., Bataille, I., Abed, A., Illoul, C., Anglo, A., Louedec, L., et al. Concentrated collagen hydrogels as dermal substitutes. Biomaterials 31, 481, 2010.
3. Rosenblatt, J., Devereux, B., and Wallace, D.G. Effect of electrostatic forces on the dynamic rheological properties of injectable collagen biomaterials. Biomaterials 13, 878, 1992.
4. Dallon, J.C., and Ehrlich, H.P. A review of fibroblast-populated collagen lattices. Wound Repair Regen 16, 472, 2008.
5. Brown, R.A., Wisema, M., Chuo, C.B., Cheema, U., and Nazhat, S.N. Ultrarapid engineering of biomimetic materials and tissues: fabrication of nano-and microstructures by plastic compression. Adv Funct Mater 15, 1762, 2005.
6. Hu, K., Shi, H., Zhu, J., Deng, D., Zhou, G., Zhang, W., et al. Compressed collagen gel as the scaffold for skin engineering. Biomed Microdevices 12, 627, 2010.
7. Mudera, V., Morgan, M., Cheema, U., Nazhat, S.N., and Brown, R.A. Ultra-rapid engineered collagen constructs tested in an in vivo nursery site. J Tissue Eng Regen Med 1, 192, 2007.
8. Ananta, M., Aulin, C.E., Hilborn, J., Aibibu, D., Houis, S., Brown, R.A., et al. A poly(lactic acid-co-caprolactone)-collagen hybrid for tissue engineering applications. Tissue Eng Part A 15, 1667, 2009.
9. Breidahl, A.F., Judson, R.T., Dumble, L.J., and Clunie, G.J. In vitro culture of disaggregated rabbit keratinocytes. Immunol Cell Biol 68, 119, 1990.
10. Takashima, A. Establishment of fibroblast cultures. In: Bonifacino, J.S., Dasso, M., Harford, J.B., et al., eds. Current Protocols in Cell Biology. New York: John Wiley & Sons, Inc.; 2001, pp. 2.1.1-2.1.12.
11. Gorham, S.D., Monsour, M.J., and Scott, R. The in vitro assessment of a collagen/vicryl (polyglactin) composite film together with candidate suture materials for use in urinary tract surgery. I. Physical testing. Urol Res 15, 53, 1987.
12. MacDonald, A., Carachi, R., and Gibson, A. A new oesophageal tube: assessment of collagen/vicryl composite membrane. J Pediatr Surg 27, 856, 1992.
13. Meddings, R.N., Carachi, R., Gorham, S., and French, D.A. A new bioprosthesis in large abdominal wall defects. J Pediatr Surg 28, 660, 1993.
14. Nakayama, G.R., Caton, M.C., Nova, M.P., and Parandoosh, Z. Assessment of the Alamar Blue assay for cellular growth and viability in vitro. J Immunol Methods 204, 205, 1997.
15. Marston, W.A., Hanft, J., Norwood, P., and Pollak, R. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care 26, 1701, 2003.
16. Omar, A.A., Mavor, A.I.D., Jones, A.M., and Homer-Vanniasinkam, S. Treatment of Venous Leg Ulcers with Dermagraft. Eur J Vasc Endovasc Surg 27, 666, 2004.
17. Falanga, V., Margolis, D., Alvarez, O., Auletta, M., Maggiacomo, F., Altman, M., et al. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent Arch Dermatol 134, 293, 1998.
18. Veves, A., Falanga, V., Armstrong, D.G., and Sabolinski, M.L. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers. Diabetes Care 24, 290, 2001.
19. Brusselaers, N., Pirayesh, A., Hoeksema, H., and Richters, C.D., Verbelen, J., Beele, H. et al. Skin replacement in burn wounds. J Trauma 68, 490, 2010.
20. Eisenberg, M., and Llewelyn, D. Surgical management of hands in children with recessive dystrophic epidermolysis bullosa: use of allogeneic composite cultured skin grafts. Br J Plast Surg 51, 608, 1998.
21. Cooper, M.L., Hansbrough, J.F., Spielvogel, R.L., Cohen, R., Bartel, R.L., and Naughton, G. In vivo optimization of a living dermal substitute employing cultured human fibroblasts on a biodegradable polyglycolic acid or polyglactin mesh. Biomaterials 12, 243, 1991.
22. Mansbridge, J., Liu, K., Patch, R., Symons, K., and Pinney, E. Three-dimensional fibroblast culture implant for the treatment of diabetic foot ulcers: metabolic activity and therapeutic range. Tissue Eng 4, 403, 1998.
23. Still, J., Glat, P., Silverstein, P., Griswold, J., and Mozingo, D. The use of a collagen sponge/living cell composite material to treat donor sites in burn patients. Burns 29, 837, 2003.
24. Bell, E., Ivarsson, B., and Merrill, C. Production of a tissuelike structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc Natl Acad Sci USA 76, 1274, 1979.
25. Bell, E., Ehrlich, H.P., Sher, S., Merrill, C., Sarber, R., Hull, B., et al. Development and use of a living skin equivalent. Plast Reconstr Surg 67, 386, 1981.
26. Bell, E., Ehrlich, H.P., Buttle, D.J., and Nakatsuji, T. Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness. Science 211, 1052, 1981.
27. Allenet, B., Paree, F., Lebrun, T., Carr, L., Posnett, J., Martini, J., et al. Cost-effectiveness modeling of Dermagraft for the treatment of diabetic foot ulcers in the french context. Diabetes Metab 26, 125, 2000.
28. Schonfeld, W.H., Villa, K.F., Fastenau, J.M., Mazonson, P.D., and Falanga, V. An economic assessment of Apligraf (Graftskin) for the treatment of hard-to-heal venous leg ulcers. Wound Repair Regen 8, 251, 2000.
29. Cheung, D.T., Perelman, N., Ko, E.C., and Nimni, M. Mechanism of crosslinking of proteins by glutaraldehyde III. Reaction with collagen in tissues. Connect Tissue Res 13, 109, 1985.
30. Kagan, H.M., and Li, W. Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell. J Cell Biochem 88, 660, 2003.
31. Piacentini, M., Rodolfo, C., Farrace, M.G., and Autuori, F. Tissue transglutaminase in animal development. Int J Dev Biol 44, 655, 2000.
32. Girton, T.S., Oegema, T.R., and Tranquillo, R.T. Exploiting glycation to stiffen and strengthen tissue equivalents for tissue engineering. J Biomed Mater Res Part A 46, 87, 1999.
33. Weadock, K.S., Miller, E.J., Bellincampi, L.D., Zawadsky, J.P., and Dunn, M.G. Physical crosslinking of collagen fibers: comparison of ultraviolet irradiation and dehydrothermal treatment. J Biomed Mater Res 29, 1373, 2004.
34. Ahearne, M., Yang, Y., Then, K.Y., and Liu, K.K. Nondestructive mechanical characterisation of UVA/riboflavin crosslinked collagen hydrogels. Br J Ophthalmol 92, 268, 2008.
35. Coulomb, B., Lebreton, C., and Dubertret, L. Influence of human dermal fibroblasts on epidermalization. J Invest Dermatol 92, 122, 1989.
36. el-Ghalbzouri, A., Gibbs, S., Lamme, E., Van Blitterswijk, C.A., and Ponec, M. Effect of fibroblasts on epidermal regeneration. Br J Dermatol 147, 230, 2002.
37. Svensjo, T., Yao, F., Pomahac, B., and Eriksson, E. Autologous keratinocyte suspensions accelerate epidermal wound healing in pigs. J Surg Res 99, 211, 2001.
38. Svensjo, T., Yao, F., Pomahac, B., Winkler, T., and Eriksson, E. Cultured autologous fibroblasts augment epidermal repair. Transplantation 73, 1033, 2002.
39. Butler, C.E., Yannas, I.V., Compton, C.C., Correia, C.A., and Orgill, D.P. Comparison of cultured and uncultured keratinocytes seeded into a collagen-GAG matrix for skin replacements. Br J Plast Surg 52, 127, 1999.
40. Cheema, U., Brown, R.A., Alp, B., and MacRobert, A.J. Spatially defined oxygen gradients and vascular endothelial growth factor expression in an engineered 3D cell model. Cell Mol Life Sci 65, 177, 2008.
41. Hadjipanayi, E., Brown, R.A., Mudera, V., Deng, D., Liu, W., and Cheema, U. Controlling physiological angiogenesis by hypoxia-induced signaling. J Control Release 146, 309, 2010.
42. Hadjipanayi, E., Cheema, U., Mudera, V., Deng, D., Liu, W., and Brown, R.A. First implantable device for hypoxiamediated angiogenic induction. J Control Release 153, 217, 2011.
43. Falanga, V., and Sabolinski, M. A bilayered living skin construct (APLIGRAF) accelerates complete closure of hardto-heal venous ulcers. Wound Repair Regen 7, 201, 1999.